Freestone Grove Partners’s Cognex CGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.2M Buy
389,605
+384,141
+7,030% +$23.3M 0.18% 164
2026
Q1
$268K Sell
5,464
-81,079
-94% -$3.79M ﹤0.01% 704
2025
Q4
$3.11M Sell
86,543
-248,045
-74% -$10M 0.02% 382
2025
Q3
$15.2M Buy
334,588
+325,213
+3,469% +$13.2M 0.11% 247
2025
Q2
$297K Buy
+9,375
New +$269K ﹤0.01% 589

Other funds holding CGNX

Freestone Grove Partners's CGNX Position: Q2 2026 in Review

Freestone Grove Partners increased its Cognex (CGNX) stake by 7,030% in Q2 2026, buying an estimated $23.3M and bringing the position to 389,605 shares worth $28.2M. The position accounts for 0.18% of the portfolio, ranked #164.

Freestone Grove Partners first reported a position in CGNX in Q2 2025 and has held it in 5 quarters since. 651 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • Freestone Grove Partners held 389,605 shares of Cognex worth $28.2M as of Q2 2026.
  • Freestone Grove Partners bought 384,141 Cognex shares in Q2 2026, an estimated $23.3M.
  • Cognex made up 0.18% of Freestone Grove Partners's portfolio in Q2 2026, its #164 holding.
  • Freestone Grove Partners first reported a position in Cognex in Q2 2025 and has held it in 5 quarters since.
  • 651 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.